Kirr Marbach & Co’s Cerence CRNC Stock Holding History

Kirr Marbach & Co’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-116,073	Closed	-$1.79M	–	59
2020 Q1	$1.79M	Sell	116,073 -69,864	-38%	-$1.47M	0.77%	41
2019 Q4	$4.21M	Buy	+185,937	New	+$3.05M	0.97%	40

Other funds holding CRNC

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Kirr Marbach & Co's CRNC Position: Q2 2020 in Review

Kirr Marbach & Co sold out of Cerence (CRNC) in Q2 2020, closing a stake of 116,073 shares — an estimated $1.79M sold.

Kirr Marbach & Co first reported a position in CRNC in Q4 2019 and held it in 2 quarters. The position peaked at $4.21M in Q4 2019. 241 funds tracked by Wall St. Rank hold CRNC as of Q2 2020.

Kirr Marbach & Co reported no remaining Cerence position as of Q2 2020 after selling out during the quarter.
Kirr Marbach & Co sold 116,073 Cerence shares in Q2 2020, an estimated $1.79M.
Kirr Marbach & Co first reported a position in Cerence in Q4 2019 and held it in 2 quarters.
Kirr Marbach & Co's Cerence position peaked at $4.21M in Q4 2019.
241 funds tracked by Wall St. Rank held Cerence as of Q2 2020.

Based on Kirr Marbach & Co's 13F filing for Q2 2020, filed 17 Jul 2020.